Loading...

PLX PROTALIX BIOTHERAPEUTICS INC Capital Structure Changes 8-K Filing

PRTL

PLX

PROTALIX BIOTHERAPEUTICS INC

(PLX)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Results

Bylaw Amendments

Stockholder Update

Financial Results

Clinical Trial Update

Financial Results

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Condition and Oth...

Financial Results Announcement

Agreement for Stock Sale

Financial Results Announcement

Regulation FD Disclosure

External Links:

On March 17, 2025, Protalix Biotherapeutics amended its agreement to increase the amount of common stock it can sell by $20 million for general corporate purposes, including funding clinical trials.

AI Assistant

PROTALIX BIOTHERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.